Seventh BHD international symposium: recent scientific and clinical advancement

Oncotarget. 2022 Jan 20:13:173-181. doi: 10.18632/oncotarget.28176. eCollection 2022.

Abstract

The 7th Birt-Hogg-Dubé (BHD) International Symposium convened virtually in October 2021. The meeting attracted more than 200 participants internationally and highlighted recent findings in a variety of areas, including genetic insight and molecular understanding of BHD syndrome, structure and function of the tumor suppressor Folliculin (FLCN), therapeutic and clinical advances as well as patients' experiences living with this malady.

Keywords: Birt-Hogg-Dubé syndrome; FLCN; LDHA; folliculin; tuberous sclerosis complex.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Birt-Hogg-Dube Syndrome* / genetics
  • Humans